Aeovian Pharmaceuticals | Valuation, Funding Rounds & Stock Price | Caplight
Aeovian Pharmaceuticals
Private
Berkeley, California
Healthcare & Life Sciences
https://www.aeovian.com/
Last Round
Series B
Dec 16, 2025
Total Funding Raised
$142M
Momentum
Top 25% of companies Caplight tracks
Company Overview
Aeovian Pharmaceuticals is a biotechnology company that develops targeted and highly selective small molecule therapeutics to restore cellular metabolic quality control for the treatment of rare and age-related diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
biotechnology, mTORC1 inhibitor, drug discovery, rare disease, Tuberous Sclerosis Complex, TSC, precision medicine, clinical-stage biotech, refractory epilepsy, CD38 inhibitor, small-molecule therapeutics, drug development, clinical trials, biotech startup, therapeutic pipeline
Historical Pricing
Unlock Pricing Charts
Caplight Momentum Score
Proprietary index based on bid/ask volume and sentiment.
View Momentum History
Aeovian Pharmaceuticals Comparables
Compare Aeovian Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cambrian Bio | 82% | Unlock |
| Aukera Therapeutics | 77% | Unlock |
| Novartis | 74% | Unlock |
| Comparable company | 50% | Unlock |
Aeovian Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 16, 2025 | Unlock | Unlock | Unlock | Unlock |
| Series A Extension | Mar 28, 2024 | Unlock | Unlock | Unlock | Unlock |
| Series A | Oct 3, 2019 | Unlock | Unlock | Unlock | Unlock |
| Seed | Dec 11, 2017 | Unlock | Unlock | Unlock | Unlock |
Key People
Founding team and executive leadership
Allison Hulme
CEO
LinkedIn profile
Micah Zajic
Chief Financial Officer
LinkedIn profile
Aeovian Pharmaceuticals Investors
| Investor | Rounds |
|---|---|
| Apollo Ventures | Seed |
| SymBiosis Capital Management | Series B |
| CTI Life Sciences Fund | Series B |
| TSC Alliance Endowment Fund | Series B |
| Hevolution Foundation | Series B, Series A Extension |
| LUMA Partners | Series B |
| Foresite Capital | Series B |
Market signals
- Jun 20, 2026
Monthly visitors increased 133% MoM, reaching 1.6K.
- Dec 16, 2025
$55M Series B round completed.
Aeovian Pharmaceuticals Filings
| Typed | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|---|---|---|---|---|---|
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
| Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Aeovian Pharmaceuticals's valuation, stock price, and market status.
- Is Aeovian Pharmaceuticals a public or private company?
- What is the current stock price of Aeovian Pharmaceuticals?
- How much is Aeovian Pharmaceuticals worth (valuation)?
- Can I buy Aeovian Pharmaceuticals stock?
- When was Aeovian Pharmaceuticals's last funding round?
- Who are the main investors in Aeovian Pharmaceuticals?
- Will Aeovian Pharmaceuticals IPO soon?
- How can I track Aeovian Pharmaceuticals secondary market activity?
Firmographic Details
Headquarters: Berkeley, California
Employee Range: 13
Year Founded: 2017
Last Funding: Dec 16, 2025